July 24, 2014 4:55 PM ET

Biotechnology

Company Overview of Oxford Gene Technology IP Limited

Executive Profile

Robert Holland

Chief Medical Officer, Oxford Gene Technology IP Limited
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
59--

Background

Dr. Robert Holland, also known as Bob, has been the Chief Medical Officer of Oxford Gene Technology IP Limited since September 2013. Dr. Holland serves as Vice President of Global Experimental Medicine at AstraZeneca. Dr. Holland has an impressive clinical track record with over 25 years experience in the pharmaceutical industry, where he has contributed to the development of significant medicines in neuroscience and oncology with combined total annual sales of $8 billion. ...

Corporate Headquarters

Begbroke Science Park
Begbroke, Oxfordshire OX5 1PF

United Kingdom

Phone: 44 1865 856800
Fax: 44 1865 848684

Board Members Memberships

2013-Present
Non-Executive Director and Member of R & D Committee
2014-Present
Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oxford Gene Technology IP Limited, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.